Volume 23, Number 4 (Biomonthly oct_Nov 2012)                   J Urmia Univ Med Sci 2012, 23(4): 432-439 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Nanbakhsh F, Broomand Sorkhabi F, Makhdoomi K, Mazloomi P, Doosti R, Lotofolah L. EFFECTS OF ANTIOXIDANTS THERAPY ON PREVENTION OF PREECLAMPSIA IN HIGH RISK PREGNANCIES. J Urmia Univ Med Sci. 2012; 23 (4) :432-439
URL: http://umj.umsu.ac.ir/article-1-1435-en.html

Reproductive Health research center, Urmia University of Medical Sciences , faribanan@yahoo.com
Abstract:   (6336 Views)

Background & Aims: Preeclampsia (PIH) is the complication of pregnancies involving   multiple systems that could cause mortality and morbidity of mothers and  infants. Recent studieshave shown that antioxidants has a protective role in pregnancy from peroxidase cellular damage, as well as a decline in antioxidants blood level in preeclamptic pregnant women. This study was amed to evaluate  the role of vitamin E and vitamin C in prevention of PIH high risk pregnancies.  

Materials & Methods: In this study we included 100 high risk patients with diabetic mellitus, chronic renal failure, chronic hypertension, patients with BMI>30, and patients with a history of previous severe PIH. All referred to Urmia Motahari hospital, since 2004 to 2009 and were randomly divided into two groups: intervention (49 patients) and control groups (51 patients). Theintervention group patients were treated with 1000 mg of vitamin C and 400 mg of vitamin E daily from 16th week of pregnancy up to delivery or termination of pregnancy due to preeclampsia, in contrast to the fact that the control group were not treated beyond their previous medications. The incidence and time of beginning of preeclampsia was compared in two groups by Q square test, and the analysis was done by Spss software.

  Results: In the end of the study 14 patients out of 49 (32%) in the intervention group became preeclamptic via 29 patients (67.4%) in control group. In comparison with the difference between was statistically meaningful with the P 0<0.05 and the odds’ ratio of 0.3.

  Conclusion: This trial demonstrates benefits of vitamin C and E supplements in reducing the rate of preeclampsia among high risk pregnancies, and we can propose to use this antioxidants to privention of preeclampsia in high risk pregnancies.

 

SOURCE: URMIA MED J 2012: 23(4): 453 ISSN: 1027-3727

 

Full-Text [PDF 217 kb]   (716 Downloads)    
Type of Study: Research | Subject: آناتومی
Received: 2012/10/14 | Accepted: 2013/03/16 | Published: 2013/03/16

Add your comments about this article : Your username or email:
Write the security code in the box

Send email to the article author


© 2015 All Rights Reserved | URMIA MEDICAL JOURNAL

Designed & Developed by : Yektaweb